ASRT vs HAS · rev $125.0M vs P/E 25, rev $4.75B
Assertio Therapeutics Inc (ASRT) versus Hasbro Inc (HAS) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
Hasbro Inc (HAS) is a leisure company listed on US.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported HAS revenue for 2024-12-29 was $4.75B. Net income was $394.4M. Revenue was down 16.9% from 2023-12-31 to 2024-12-29. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
ASRT currently screens at market cap $151.5M. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
Not investment advice. Open the ASRT and HAS stock pages for the full models.
Not investment advice.